Diagnosis
The first duty of a surgeon to a patient with a lump in the breast is to establish a definitive diagnosis as soon as possible. Even if meticulous interrogation and examination are practised, the accuracy of diagnosis is considerably enhanced by the use of mammography. From an experience of over 2,000 mammograms, Stewart et al. (1969) have reported from Cardiff that radiological examination of the breast had an overall accuracy of 93 % for both benign and neoplastic conditions. In Table 1 the diagnostic accuracy of mammography and clinical examination has been compared in 144 cancers and 335 benign lesions, all proved histologically. Both mammographic and clinical diagnoses were recorded without the findings of the other being known. The accuracy of either mammography or clinical examination alone is approximately 90%, but when both methods are combined the accuracy is increased to 97 %.
In our experience, thermography, using the AGA machine, does not approach this accuracy. As part of an investigation of diagnostic methods, a blind comparison of thermography with clinical examination and conventional mammography is being carried out. To date, thermography has compared unfavourably with these other methods of examination (Table 2 ). In this table the accuracy of thermography is given both for an agreed diagnosis and for the majority diagnosis of 3 observers, each of whom assessed the thermograms separately; considerable observer error is noted.
Even with the availability of these methods, histology is still the only certain method of diagnosis. This can be obtained on the day the patient attends the clinic by drill biopsy or, more simply, by needle aspiration. Our experience of the latter method, although small, is similar to that reported by others and gives an accuracy of diagnosis for cancer of around 70% (Table 3) . However, it is important to appreciate that a negative aspirate does not rule out cancer. Operability If a diagnosis of cancer is suspected, the next duty of the surgeon is to establish that the tumour is operable. This deds a diligent search for metastases. In our clinic this includos graphy of the other breast, X-ray of the sul, chest and pelvis (where bone metastases are frequently symptomless) and, if the tumour is medially placed, biopsy of an internal mammary node at the time of surgery. The yield, although small, is well worth while, as in the patient whose radiograph ofthe skull is shown in Fig 1 and who, as a result, avoided a mutilating operati. A strict discipline is necessary for screening patients for occult metastases, and this is aided by the use of a check list and the TNM system of classification". Such investigations are time consuming and costly and cannot be carried out in all patients with lumps in the breast without increasing the axiety of -those with benign lesions. Henc the need for as accurate a diagnosis as possible before the patient comes to operation.
Treatment
It is over 60 years since Halsted described the radical operation for cancer of the breast. Yet we do not know whether this is or is not the operation of choice for the disease. Radiotherapists have similar doubts about the place of X-ray therapy as adjuvant treatment. There is, as a result, a state of uncertainty as to how breast cancer should be treated and many have reverted to what time may show to be inadequate methods of treatment.
Doubts such as these can be resolved only if we recognize the importance of the controlled clinical trial as a therapeutic weapon.
It is our belief that the aimn of treatment of primary cancer of the breast is to control the local manifestations of the disease with minimum mutilation and morbidity. This belief is based on the following considerations: (1) Simple mastectomy and X-ray tbheapy by the McWhirter technique give results jequal to the most radical operations. Thus, Kaae & Johansen (1968) descibed identical suivaln recurrce rates over ten years for 331 patients treated by simple mastectomy and X-ray therapy and 335 patients tated by an extended radical operation in which the bret and the axillary, supraclavicular and internal mammary nodes were removed surgically.
(2) Extension of local treatment beyond the breast and axilla confers no advantage over keeping such treatment in reserve until demanded by recurrence. Thus, Easson (1968) reports equal survival rates over ten years for 752 patients in whom the initial treatment was radical mastectomy alone (X-ray therapy being reserved for recurrence) compared with 709 patients in whom radical mastectomy was combined with postoperative X-ray therapy.
(3) Surgery and X-ray therapy are equally effective in treating involved nodes. This assumption is supported by the results of all three trials, but particularly by those from Copenhagen and Section ofRadiology Cambridge, in which patients treated only by X-ray therapy to the nodal areas fared equally well as those in whom surgery or surgery plus X-ray therapy was used.
Incurability: It has long been recognized that the extent of the disease, in terms of axillary node involvement, is the best guide to prognosis (Cutler 1966) . The greater the number of axillary nodes involved, the worse the prognosis (Pickren 1961) . As a result of histological examination of all the axillary nodes in 204 mastectomy specimens, Auchincloss (1963) found that five-year survival was recorded only if involvement of the nodes was limited to the lower axilla. Lymphatic spread above the lower border of the pectoralis minor muscle was indicative of incurable disease. Local treatment, no matter how radical, cannot cure incurable disease.
Morbidity: The morbidity of local treatment of cancer of the breast is proportional to its extent. In a meticulous study of 252 patients (229 treated by radical and 23 by limited mastectomy) Eisenberg & Goldenberg (1966) found that morbidity, in terms of arm swelling, impairment of function and inability to resume normal activity, was greater with radical mastectomy than with the simpler operation (Table 4 ). Seventy-five of their patients had also been treated by postoperative radiotherapy and, of these, 43 % had a severe reaction with blistering of the skin, severe nausea, weakness or fatigue. The Halsted operation carries a further disadvantage in that a woman without a pectoral muscle complains that she can no longer wear a swim-suit or a low-necked garment. Provided it does not compromise cure rates, preferable treatment is that which carries least morbidity. (Cutler 1968 ) and sinus histiocytosis (Black 1965) of the regional nodes, have a relatively good prognosis compared with those in whom the changes are less obvious.
Disturbance of this response at the time of primary treatment, for instance by removal or radiation of normal nodes, may be contrary to the interests of tumour control.
Multicentric origin: As a result of examining whole breast sections of 157 breasts removed for cancer, Qualheim & Gall (1957) reported multiple tumour foci in 54 % of cases. In 37 % the unconnected tumours occupied opposite portions of the breast. Similar results were found by Stewart (1968, unpublished) in our laboratories. Fifty breasts, resected for tumour, were prepared by the large-section technique of Gough & Wentworth (1960) : multifocal deposits were found in 38%. 'Lumpectomy' will leave residual tumour, therefore, in one-third of cases.
Cardiff Trial
As a result of these considerations, we have adopted a plan of treatment based on the following principles:
(1) Treatment by surgery or X-rays should be given only to sites of proved involvement: excess removal or irradiation of normal tissues increases morbidity but not cure.
(2) Because of the probability of multifocal origin, local mastectomy is the minimum acceptable operation for primary breast cancer.
(3) Surgical excision and X-ray therapy are equally effective methods of treatment for involved lymph nodes.
(4) Substantial axillary node involvement signifies incurable disease.
In accordance with these principles, our standard operation is a local mastectomy. This is performed through a transverse incision, which gives minimal tension and a relatively inconspicuous scar. The axillary tail is completely removed with two of three of the lower pectoral group of nodes which lie in close association to it. The axillary fascia is not disturbed unless palpable nodes are prent in the axilla, when one or two are rtmoved for histolog examination. A smal pieo of skin aso is removed from the edge of the incsion nearest to the excised tumour. Rapid return of function is encouraged by suction a mnimum of dressings and early mobilization.
Subsequent treatment by radiotherapy is dictated by the histological state of the removed nodes and skin. If no metastases are presnt, no further treatment is given but normal lymphatic function is preserve. If the pectoral or lower axillary nodes are involved, radiotherapy is given postoperatively to the axilla alone by a course of treatment of 4,000 rads fractionated into ten separate treatments over three weeks using cobalt irradiation. This regime was adopted as there is now some evidence from animal experiments (Du Sault et al; 1958) and colected data from a number of tAtment centres (Cohen 1966) that, in the case of mammary carcinoma, treatmaet on alternate days gives a better therapeutic ratio than daily treatment. Radiotherapy to the skin flap, using a similar regime, is given only if the biopsy of skin contains tumour cells.
This plan of treatment is currently being compared randomly with a standard regime based on radical or modified radical mastectomy, by which the axilla is cleared of lymph nodes in all cs. In this group radical radiotherapy is given to the ailla, supraclavicular and internal mammary regions and chest wall if the axilary nodes and/or skin biopsy are positive. The total doses given are 4,00 rads to the chest wall, 3,500 ads to the supraclavicular and internal mammary fieds and 4,O) rads to the axilla, fractionated over aperiod of four weeks. The chest wall and gland field are treated on alternate days. The dose regime is based upon that of De Moor et al. (1961) which was shown to give a very low incidence of local recurrence following radical mastectomy.
No adjuvznt endocrine or cytotoxic therapy is given to either group.
This trial, which started in September 1967, now inudes 43 patients, of whom 22 have been allocated to the conservative and 21 to the radical groups.
Before being randomized into the trial, patints are staged carefully by a surgeon and a pt, according to the TNM claification. Only those patients with TlNo, TlNl, I2No and T2N1 tumours are included. The tumour stage is ded together with the nmammogaphic findings and the results of the skeletal survey. Tb foms ued are co subsequently and inc2sde the details of treatment and1he plan of radkoterapy, if given. In addition, the detailed histolgcal or of the tumour, the lymph node and skin biopsies are induded. Estimations of urinary androgenic steroids and corticosteroids are being done in all patients.
In the t of the results, not only will survival and diseaso recune be analyed-but the quality of life will be carefidly documented. Provided there is no risk to the patient, a policy of treatment based on the principle that normal tissues should not be int d with is both rational and desirable, and will save needless physical and mental scarring.
